MRC Unit The Gambia at London School of Hygiene and Tropical Medicine, Serrekunda, The Gambia; MRC Nutrition and Bone Health Research Group, Cambridge, United Kingdom; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
MRC Unit The Gambia at London School of Hygiene and Tropical Medicine, Serrekunda, The Gambia.
Am J Clin Nutr. 2024 Jun;119(6):1443-1454. doi: 10.1016/j.ajcnut.2024.02.025. Epub 2024 Apr 18.
The World Health Organization recommends calcium supplementation (1500-2000 mg/d) during pregnancy for women with a low-calcium intake.
The purpose of this study was to investigate whether pregnancy calcium supplementation affects offspring blood pressure and growth in The Gambia where calcium intakes are low (300-400 mg/d).
Follow-up of offspring born during a randomized controlled trial of pregnancy calcium supplementation (ISRCTN96502494, 1996-2000) in which mothers were randomly assigned to 1500 mg Ca/d (Ca) or placebo (P) from 20 wk pregnancy to delivery. Offspring were enrolled at age 3 y in studies where blood pressure and anthropometry were measured under standardized conditions at approximately 2-yearly intervals. Mean blood pressure and growth curves were fitted for females and males separately, using the longitudinal SuperImposition by Translation and Rotation (SITAR) mixed effects model. This generates 3 individual-specific random effects: size, timing, and intensity, reflecting differences in size, age at peak velocity, and peak velocity through puberty relative to the mean curve, respectively.
Five hundred twenty-three singleton infants were born during the trial (maternal group assignment: Ca/P = 259/264). Four hundred ninety-one were enrolled as children (females: F-Ca/F-P = 122/129 and males: M-Ca/M-P = 119/121) and measured regularly from 3.0 y to mean age 18.4 y; 90% were measured on ≥8 occasions. SITAR revealed differences in the systolic blood pressure and height curves between pregnancy supplement groups in females, but not in males. F-Ca had lower systolic blood pressure than F-P at all ages (size = -2.1 ± SE 0.8 mmHg; P = 0.005) and lower peak height velocity (intensity = -2.9 ± SE 1.1%, P = 0.009). No significant pregnancy supplement effects were seen for other measures.
This study showed, in female offspring, that pregnancy calcium supplementation may lower systolic blood pressure and slow linear growth in childhood and adolescence, adding to evidence of offspring sexual dimorphism in responses to maternal supplementation. Further research is warranted on the long-term and intergenerational effects of antenatal supplementations. This trial was registered at ISRCTN Registry as ISRCTN96502494.
世界卫生组织建议孕妇低钙摄入时进行钙补充(1500-2000 毫克/天)。
本研究旨在探讨在钙摄入量较低(300-400 毫克/天)的冈比亚,妊娠补钙是否会影响后代的血压和生长。
对一项妊娠补钙随机对照试验(ISRCTN96502494,1996-2000 年)中出生的后代进行随访,母亲在妊娠 20 周时被随机分配至 1500 毫克钙/天(钙)或安慰剂(P)组至分娩。在大约每两年一次的标准化条件下测量血压和人体测量学,在 3 岁时招募后代进行研究。使用纵向平移和旋转叠加(SITAR)混合效应模型分别为女性和男性拟合平均血压和生长曲线。这会生成 3 个个体特异性随机效应:大小、时间和强度,分别反映相对于平均曲线的大小、峰值速度时的年龄以及青春期内的峰值速度的差异。
试验期间共出生 523 名单胎婴儿(母亲组分配:钙/安慰剂=259/264)。491 名作为儿童入组(女性:F-Ca/F-P=122/129 和男性:M-Ca/M-P=119/121),并从 3.0 岁至平均 18.4 岁定期测量;90%的人至少测量了 8 次。SITAR 显示,在女性中,补充组之间的收缩压和身高曲线存在差异,但在男性中没有。F-Ca 的收缩压在所有年龄都低于 F-P(大小=-2.1±SE0.8mmHg;P=0.005),且峰值身高速度较低(强度=-2.9±SE1.1%;P=0.009)。未观察到其他措施有显著的妊娠补充效果。
本研究表明,在女性后代中,妊娠补钙可能会降低儿童期和青春期的收缩压和线性生长速度,这增加了后代对母体补充剂反应的性别二态性的证据。需要进一步研究产前补充剂的长期和代际影响。本试验在 ISRCTN 注册处注册为 ISRCTN96502494。